Association between glaucomatous optic disc and depressive symptoms independent of light exposure profiles: a cross-sectional study of the HEIJO-KYO cohort.
Yoshikawa Tadanobu, Obayashi Kenji, Miyata Kimie, Ueda Tetsuo, Kurumatani Norio, Saeki Keigo, Ogata Nahoko
AI Summary
This study found glaucoma's optic disc changes are significantly associated with higher depressive symptoms in the elderly, independent of daily light exposure, highlighting a direct link.
Abstract
Background
Glaucoma may cause physiological and behavioural circadian misalignment because of the loss of intrinsically photosensitive retinal ganglion cells, the primary receptors of environmental light. Although studies have suggested a high prevalence of depression in patients with glaucoma, it is unclear whether the association is independent of the light exposure profiles as an important confounding factor.
Methods
In this cross-sectional study of a community-based cohort of 770 elderly individuals (mean age, 70.9 years), glaucomatous optic discs were assessed using fundus photographs and depressive symptoms were assessed using the short version of the Geriatric Depression Scale (GDS). Daytime and night-time ambient light exposures were objectively measured for 2 days.
Results
Depressive symptoms (GDS score ≥6) were observed in 114 participants (prevalence, 14.8%) and glaucomatous optic discs were detected in 40 participants (prevalence, 5.2%). The prevalence of depressive symptoms was significantly higher in the group with glaucomatous optic disc than in the group without it (30.0% vs 14.0%, respectively; p=0.005). Multivariable logistic regression analysis adjusted for potential confounding factors, including daytime and night-time light exposures, revealed that the OR for depressive symptoms was significantly higher in the group with glaucomatous optic disc than in the group without it (OR 2.45, 95% CI 1.18 to 5.08; p=0.016).
Conclusions
In this general elderly population, glaucomatous optic disc was significantly associated with higher prevalence of depressive symptoms independent of a number of potential confounding factors, including daily light exposure profiles.
MeSH Terms
Shields Classification
Key Concepts5
In a cross-sectional study of 770 elderly individuals (mean age, 70.9 years) from the HEIJO-KYO cohort, the prevalence of depressive symptoms was significantly higher in the group with glaucomatous optic disc (30.0%) than in the group without it (14.0%; p=0.005).
In a multivariable logistic regression analysis adjusted for potential confounding factors, including daytime and night-time light exposures, in a cross-sectional study of 770 elderly individuals (mean age, 70.9 years) from the HEIJO-KYO cohort, the odds ratio for depressive symptoms was significantly higher in the group with glaucomatous optic disc than in the group without it (OR 2.45, 95% CI 1.18 to 5.08; p=0.016).
In a general elderly population from the HEIJO-KYO cohort, glaucomatous optic disc was significantly associated with a higher prevalence of depressive symptoms, independent of a number of potential confounding factors, including daily light exposure profiles.
In a cross-sectional study of 770 elderly individuals (mean age, 70.9 years) from the HEIJO-KYO cohort, depressive symptoms (Geriatric Depression Scale score ≥6) were observed in 114 participants, indicating a prevalence of 14.8%.
In a cross-sectional study of 770 elderly individuals (mean age, 70.9 years) from the HEIJO-KYO cohort, glaucomatous optic discs were detected in 40 participants, indicating a prevalence of 5.2%.
Related Articles5
The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom.
Observational StudyThe Association Between Intermittent Fasting and Glaucoma.
Cross-Sectional StudySingapore Chinese Eye Study: key findings from baseline examination and the rationale, methodology of the 6-year follow-up series.
Cohort StudyOptic neuropathy in uraemic patients on dialysis.
Cohort StudyAssociation of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.